documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
32,231 rows where document_type = "Supporting & Related Material" and posted_year = 2024 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: posted_month, withdrawn, posted_date (date), last_modified (date)
agency_id >30
posted_year 1
- 2024 · 32,231 ✖
document_type 1
- Supporting & Related Material · 32,231 ✖
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| APHIS-2022-0061-0004 | APHIS | Creation of United States Swine Health Improvement Plan APHIS-2022-0061 | US SHIP Program Standards | Supporting & Related Material | Guidance | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T14:13:38Z | 0 | 0 | 0900006486888ffb | |||
| APHIS-2023-0088-0004 | APHIS | Revise conditions for payment of indemnity and compensation for HPAI APHIS-2023-0088 | Biosecurity Audit Tool | Supporting & Related Material | Supplement | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T14:16:16Z | 0 | 0 | 090000648688880f | |||
| APHIS-2022-0061-0002 | APHIS | Creation of United States Swine Health Improvement Plan APHIS-2022-0061 | PRA Abstract | Supporting & Related Material | Paperwork Packages | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T14:13:21Z | 0 | 0 | 0900006486888ffd | |||
| APHIS-2023-0088-0003 | APHIS | Revise conditions for payment of indemnity and compensation for HPAI APHIS-2023-0088 | Information Collection Abstract | Supporting & Related Material | Paperwork Packages | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T14:16:11Z | 0 | 0 | 0900006486888a96 | |||
| APHIS-2023-0088-0002 | APHIS | Revise conditions for payment of indemnity and compensation for HPAI APHIS-2023-0088 | Initial Regulatory Flexibility Analysis (Economic Analysis) | Supporting & Related Material | Economic Analysis | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T14:16:02Z | 0 | 0 | 0900006486888ffa | |||
| APHIS-2022-0061-0003 | APHIS | Creation of United States Swine Health Improvement Plan APHIS-2022-0061 | Initial Economic Analysis | Supporting & Related Material | Economic Analysis | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T14:13:32Z | 0 | 0 | 0900006486888ffc | |||
| DEA-2024-0148-0004 | DEA | Schedules of Controlled Substances: Placement of Seven Specific Fentanyl-Related Substances in Schedule I of the Controlled Substances Act (DEA1457) DEA-2024-0148 | 7-FRS HHS 8FA Review | Supporting & Related Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T17:10:13Z | 0 | 0 | 09000064868970a9 | ||||
| DEA-2024-0148-0003 | DEA | Schedules of Controlled Substances: Placement of Seven Specific Fentanyl-Related Substances in Schedule I of the Controlled Substances Act (DEA1457) DEA-2024-0148 | SIGNED OASH to DEA letter 7FRS 8FA_10.25.24 | Supporting & Related Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T17:09:46Z | 0 | 0 | 09000064868970aa | ||||
| DEA-2024-0148-0005 | DEA | Schedules of Controlled Substances: Placement of Seven Specific Fentanyl-Related Substances in Schedule I of the Controlled Substances Act (DEA1457) DEA-2024-0148 | 7-FRS DEA 8 Factor Analysis_2024 | Supporting & Related Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T17:10:26Z | 0 | 0 | 09000064868970a8 | ||||
| EPA-HQ-OPPT-2024-0501-0003 | EPA | None EPA-HQ-OPPT-2024-0501 | High-Priority Substance Designations Under the Toxic Substances Control Act (TSCA) and Initiation of Risk Evaluation on High-Priority Substances; Notice of Availability, December 2024 | Supporting & Related Material | Publication - Previous/Related FR Notice | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-01T01:45:59Z | 0 | 0 | 090000648687c2b9 | |||
| EPA-HQ-OPPT-2024-0501-0007 | EPA | None EPA-HQ-OPPT-2024-0501 | Preliminary List Identifying Manufacturers Subject to Fee Obligations for EPA-Initiated Risk Evaluations of Chemical, 4,4′-Methylene bis(2-chloroaniline) (MBOCA), CAS #: 101-14-4 | Supporting & Related Material | Data | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-01T01:47:04Z | 0 | 0 | 090000648687c2f9 | |||
| EPA-HQ-OPPT-2024-0501-0004 | EPA | None EPA-HQ-OPPT-2024-0501 | Fees for the Administration of the Toxic Substances Control Act Final Rule, October 2018 | Supporting & Related Material | Publication - Previous/Related FR Notice | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-01T01:45:46Z | 0 | 0 | 090000648687c2ba | |||
| EPA-HQ-OPPT-2024-0501-0005 | EPA | None EPA-HQ-OPPT-2024-0501 | Initiation of Prioritization Under the Toxic Substances Control Act (TSCA); Request for Comment, December 2023 | Supporting & Related Material | Publication - Previous/Related FR Notice | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-01T01:47:30Z | 0 | 0 | 090000648687c2bb | |||
| EPA-HQ-OPPT-2024-0501-0009 | EPA | None EPA-HQ-OPPT-2024-0501 | Preliminary List Identifying Manufacturers Subject to Fee Obligations for EPA-Initiated Risk Evaluations of Chemical, Benzenamine, CAS #: 62-53-3 | Supporting & Related Material | Data | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-01T01:46:38Z | 0 | 0 | 090000648687c2fb | |||
| EPA-HQ-OPPT-2024-0501-0002 | EPA | None EPA-HQ-OPPT-2024-0501 | Fees for the Administration of the Toxic Substances Control Act (TSCA) Final Rule, February 2024 | Supporting & Related Material | Publication - Previous/Related FR Notice | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-01T01:46:12Z | 0 | 0 | 090000648687c2b8 | |||
| EPA-HQ-OPPT-2024-0501-0008 | EPA | None EPA-HQ-OPPT-2024-0501 | Preliminary List Identifying Manufacturers Subject to Fee Obligations for EPA-Initiated Risk Evaluations of Chemical, Acrylonitrile, CAS #: 107-13-1 | Supporting & Related Material | Data | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-01T01:47:17Z | 0 | 0 | 090000648687c2fa | |||
| EPA-R09-OW-2023-0623-0109 | EPA | None EPA-R09-OW-2023-0623 | Response to Comments CTV-I 26R (12.30.24) | Supporting & Related Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-01T01:54:39Z | 0 | 0 | 090000648689625e | ||||
| EPA-HQ-OPPT-2024-0501-0006 | EPA | None EPA-HQ-OPPT-2024-0501 | Preliminary List Identifying Manufacturers Subject to Fee Obligations for EPA-Initiated Risk Evaluations of Chemical, Acetaldehyde, CAS #: 75-07-0 | Supporting & Related Material | Data | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-01T01:46:25Z | 0 | 0 | 090000648687c2f8 | |||
| EPA-HQ-OPPT-2024-0501-0010 | EPA | None EPA-HQ-OPPT-2024-0501 | Preliminary List Identifying Manufacturers Subject to Fee Obligations for EPA-Initiated Risk Evaluations of Chemical, Vinyl Chloride, CAS #: 75-01-4 | Supporting & Related Material | Data | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-01-01T01:46:51Z | 0 | 0 | 090000648687c2fc | |||
| FAA-2024-2718-0002 | FAA | None FAA-2024-2718 | U.S. DOT/FAA - Supplemental AD Documents | Supporting & Related Material | Supplement | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T16:17:05Z | 0 | 0 | 090000648689700b | |||
| FAA-2024-2717-0002 | FAA | None FAA-2024-2717 | U.S. DOT/FAA - Supplemental AD Documents | Supporting & Related Material | Supplement | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T15:35:23Z | 0 | 0 | 0900006486896f92 | |||
| FDA-2022-N-2390-0097 | FDA | None FDA-2022-N-2390 | Exhibit 208 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:29:54Z | 0 | 0 | 09000064868a2ef0 | |||
| FDA-2022-N-2390-0128 | FDA | None FDA-2022-N-2390 | Exhibit 239 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:26:26Z | 0 | 0 | 09000064868a2f37 | |||
| FDA-2022-N-2390-0123 | FDA | None FDA-2022-N-2390 | Exhibit 234 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:26:56Z | 0 | 0 | 09000064868a2f32 | |||
| FDA-2022-N-2390-0126 | FDA | None FDA-2022-N-2390 | Exhibit 237 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:26:37Z | 0 | 0 | 09000064868a2f35 | |||
| FDA-2022-N-2390-0090 | FDA | None FDA-2022-N-2390 | Exhibit 201 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:29:04Z | 0 | 0 | 09000064868a2ee9 | |||
| FDA-2022-N-2390-0096 | FDA | None FDA-2022-N-2390 | Exhibit 207 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:29:48Z | 0 | 0 | 09000064868a2eef | |||
| FDA-2022-N-2390-0127 | FDA | None FDA-2022-N-2390 | Exhibit 238 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:26:31Z | 0 | 0 | 09000064868a2f36 | |||
| FDA-2022-N-2390-0088 | FDA | None FDA-2022-N-2390 | Exhibit 199 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:28:52Z | 0 | 0 | 09000064868a3103 | |||
| FDA-2022-N-2390-0103 | FDA | None FDA-2022-N-2390 | Exhibit 214 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:32:27Z | 0 | 0 | 09000064868a2f07 | |||
| FDA-2022-N-2390-0115 | FDA | None FDA-2022-N-2390 | Exhibit 226 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:31:14Z | 0 | 0 | 09000064868a2f1d | |||
| FDA-2022-N-2390-0101 | FDA | None FDA-2022-N-2390 | Exhibit 212 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:32:37Z | 0 | 0 | 09000064868a2f05 | |||
| FDA-2022-N-2390-0107 | FDA | None FDA-2022-N-2390 | Exhibit 218 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:32:05Z | 0 | 0 | 09000064868a2f0b | |||
| FDA-2022-N-2390-0120 | FDA | None FDA-2022-N-2390 | Exhibit 231 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:30:47Z | 0 | 0 | 09000064868a2f2f | |||
| FDA-2022-N-2390-0105 | FDA | None FDA-2022-N-2390 | Exhibit 216 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:32:18Z | 0 | 0 | 09000064868a2f09 | |||
| FDA-2022-N-2390-0106 | FDA | None FDA-2022-N-2390 | Exhibit 217 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:32:11Z | 0 | 0 | 09000064868a2f0a | |||
| FDA-2022-N-2390-0111 | FDA | None FDA-2022-N-2390 | Exhibit 222 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:31:39Z | 0 | 0 | 09000064868a2f19 | |||
| FDA-2022-N-2390-0113 | FDA | None FDA-2022-N-2390 | Exhibit 224 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:31:26Z | 0 | 0 | 09000064868a2f1b | |||
| FDA-2022-N-2390-0079 | FDA | None FDA-2022-N-2390 | Exhibit 190 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:27:08Z | 0 | 0 | 09000064868a27cf | |||
| FDA-2022-N-2390-0084 | FDA | None FDA-2022-N-2390 | Exhibit 195 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:28:11Z | 0 | 0 | 09000064868a28ff | |||
| FDA-2022-N-2390-0098 | FDA | None FDA-2022-N-2390 | Exhibit 209 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:29:59Z | 0 | 0 | 09000064868a2ef1 | |||
| FDA-2022-N-2390-0074 | FDA | None FDA-2022-N-2390 | Index to Exhibits | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:25:42Z | 0 | 0 | 09000064868a4593 | |||
| FDA-2022-N-2390-0080 | FDA | None FDA-2022-N-2390 | Exhibit 191 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:27:13Z | 0 | 0 | 09000064868a28fb | |||
| FDA-2022-N-2390-0085 | FDA | None FDA-2022-N-2390 | Exhibit 196 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:28:17Z | 0 | 0 | 09000064868a3100 | |||
| FDA-2022-N-2390-0100 | FDA | None FDA-2022-N-2390 | Exhibit 211 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:30:11Z | 0 | 0 | 09000064868a2f04 | |||
| FDA-2022-N-2390-0102 | FDA | None FDA-2022-N-2390 | Exhibit 213 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:32:32Z | 0 | 0 | 09000064868a2f06 | |||
| FDA-2022-N-2390-0104 | FDA | None FDA-2022-N-2390 | Exhibit 215 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:32:23Z | 0 | 0 | 09000064868a2f08 | |||
| FDA-2022-N-2390-0112 | FDA | None FDA-2022-N-2390 | Exhibit 223 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:31:32Z | 0 | 0 | 09000064868a2f1a | |||
| FDA-2022-N-2390-0114 | FDA | None FDA-2022-N-2390 | Exhibit 225 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:31:20Z | 0 | 0 | 09000064868a2f1c | |||
| FDA-2022-N-2390-0117 | FDA | None FDA-2022-N-2390 | Exhibit 228 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:31:03Z | 0 | 0 | 09000064868a2f1f | |||
| FDA-2022-N-2390-0083 | FDA | None FDA-2022-N-2390 | Exhibit 194 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:27:40Z | 0 | 0 | 09000064868a28fe | |||
| FDA-2022-N-2390-0094 | FDA | None FDA-2022-N-2390 | Exhibit 205 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:29:37Z | 0 | 0 | 09000064868a2eed | |||
| FDA-2022-N-2390-0089 | FDA | None FDA-2022-N-2390 | Exhibit 200 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:28:58Z | 0 | 0 | 09000064868a3104 | |||
| FDA-2022-N-2390-0075 | FDA | None FDA-2022-N-2390 | Exhibit 186 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:25:49Z | 0 | 0 | 09000064868a27cb | |||
| FDA-2022-N-2390-0076 | FDA | None FDA-2022-N-2390 | Exhibit 187 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:25:55Z | 0 | 0 | 09000064868a27cc | |||
| FDA-2022-N-2390-0099 | FDA | None FDA-2022-N-2390 | Exhibit 210 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:30:05Z | 0 | 0 | 09000064868a2ef2 | |||
| FDA-2022-N-2390-0124 | FDA | None FDA-2022-N-2390 | Exhibit 235 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:26:49Z | 0 | 0 | 09000064868a2f33 | |||
| FDA-2022-N-2390-0122 | FDA | None FDA-2022-N-2390 | Exhibit 233 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:30:36Z | 0 | 0 | 09000064868a2f31 | |||
| FDA-2022-N-2390-0109 | FDA | None FDA-2022-N-2390 | Exhibit 220 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:31:53Z | 0 | 0 | 09000064868a2f0d | |||
| FDA-2022-N-2390-0086 | FDA | None FDA-2022-N-2390 | Exhibit 197 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:28:27Z | 0 | 0 | 09000064868a3101 | |||
| FDA-2022-N-2390-0092 | FDA | None FDA-2022-N-2390 | Exhibit 203 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:29:18Z | 0 | 0 | 09000064868a2eeb | |||
| FDA-2022-N-2390-0095 | FDA | None FDA-2022-N-2390 | Exhibit 206 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:29:43Z | 0 | 0 | 09000064868a2eee | |||
| FDA-2022-N-2390-0129 | FDA | None FDA-2022-N-2390 | Exhibit 240 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:26:19Z | 0 | 0 | 09000064868a2f38 | |||
| FDA-2022-N-2390-0093 | FDA | None FDA-2022-N-2390 | Exhibit 204 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:29:32Z | 0 | 0 | 09000064868a2eec | |||
| FDA-2022-N-2390-0116 | FDA | None FDA-2022-N-2390 | Exhibit 227 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:31:09Z | 0 | 0 | 09000064868a2f1e | |||
| FDA-2022-N-2390-0118 | FDA | None FDA-2022-N-2390 | Exhibit 229 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:30:57Z | 0 | 0 | 09000064868a2f20 | |||
| FDA-2022-N-2390-0110 | FDA | None FDA-2022-N-2390 | Exhibit 221 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:31:47Z | 0 | 0 | 09000064868a2f18 | |||
| FDA-2022-N-2390-0121 | FDA | None FDA-2022-N-2390 | Exhibit 232 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:30:41Z | 0 | 0 | 09000064868a2f30 | |||
| FDA-2022-N-2390-0078 | FDA | None FDA-2022-N-2390 | Exhibit 189 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:26:07Z | 0 | 0 | 09000064868a27ce | |||
| FDA-2022-N-2390-0091 | FDA | None FDA-2022-N-2390 | Exhibit 202 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:29:10Z | 0 | 0 | 09000064868a2eea | |||
| FDA-2022-N-2390-0125 | FDA | None FDA-2022-N-2390 | Exhibit 236 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:26:43Z | 0 | 0 | 09000064868a2f34 | |||
| FDA-2022-N-2390-0077 | FDA | None FDA-2022-N-2390 | Exhibit 188 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:26:01Z | 0 | 0 | 09000064868a27cd | |||
| FDA-2022-N-2390-0081 | FDA | None FDA-2022-N-2390 | Exhibit 192 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:27:20Z | 0 | 0 | 09000064868a28fc | |||
| FDA-2022-N-2390-0087 | FDA | None FDA-2022-N-2390 | Exhibit 198 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:28:46Z | 0 | 0 | 09000064868a3102 | |||
| FDA-2022-N-2390-0082 | FDA | None FDA-2022-N-2390 | Exhibit 193 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:27:25Z | 0 | 0 | 09000064868a28fd | |||
| FDA-2022-N-2390-0119 | FDA | None FDA-2022-N-2390 | Exhibit 230 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:30:51Z | 0 | 0 | 09000064868a2f21 | |||
| FDA-2022-N-2390-0108 | FDA | None FDA-2022-N-2390 | Exhibit 219 | Supporting & Related Material | Background Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2025-04-04T15:31:58Z | 0 | 0 | 09000064868a2f0c | |||
| FMCSA-2024-0317-0001 | FMCSA | None FMCSA-2024-0317 | Colorado Huntsman Transport, Inc. Exemption Application | Supporting & Related Material | Petition | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T14:55:44Z | 0 | 0 | 0900006486896f0b | |||
| FWS-HQ-ES-2023-0033-0013 | FWS | Endangered and Threatened Wildlife and Plants; Endangered Species Status for the Blue Tree Monitor FWS-HQ-ES-2023-0033 | 100-word summary blue tree monitor proposed listing rule | Supporting & Related Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T13:35:26Z | 0 | 0 | 0900006486883163 | ||||
| FWS-HQ-ES-2023-0033-0011 | FWS | Endangered and Threatened Wildlife and Plants; Endangered Species Status for the Blue Tree Monitor FWS-HQ-ES-2023-0033 | Emergency Petition to List the Blue Tree Monitor Lizard (Varanus Macraei) as Endangered Under the Endangered Species Act | Supporting & Related Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T13:35:25Z | 0 | 0 | 090000648688208f | ||||
| FWS-HQ-ES-2023-0033-0010 | FWS | Endangered and Threatened Wildlife and Plants; Endangered Species Status for the Blue Tree Monitor FWS-HQ-ES-2023-0033 | Proposed Rule Literature Cited | Supporting & Related Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T13:35:25Z | 0 | 0 | 0900006486881d13 | ||||
| FWS-HQ-ES-2023-0033-0012 | FWS | Endangered and Threatened Wildlife and Plants; Endangered Species Status for the Blue Tree Monitor FWS-HQ-ES-2023-0033 | Draft Species Status Assessment for the Blue Tree Monitor (Varanus Macraei) | Supporting & Related Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T13:35:26Z | 0 | 0 | 0900006486882090 | ||||
| FWS-HQ-ES-2023-0033-0009 | FWS | Endangered and Threatened Wildlife and Plants; Endangered Species Status for the Blue Tree Monitor FWS-HQ-ES-2023-0033 | Temporary Rule Emergency Action Literature Cited | Supporting & Related Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T13:34:59Z | 0 | 0 | 09000064868814ef | ||||
| MSHA-2024-0068-0002 | MSHA | Information Collection: Main fan operation and inspection (I-A, II-A, III, and V-A mines) MSHA-2024-0068 | 1219-0030 Supporting Statement 2025 | Supporting & Related Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T12:12:37Z | 0 | 0 | 09000064868953d3 | ||||
| MSHA-2024-0067-0002 | MSHA | Information Collection: Ground Control for Surface Coal Mines and Surface Work Areas of Underground Coal Mines MSHA-2024-0067 | 1219-0026 Supporting Statement 2025 | Supporting & Related Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T12:12:04Z | 0 | 0 | 09000064868953d4 | ||||
| NOAA-NMFS-2024-0146-0002 | NOAA | International Fisheries; Pacific Tuna Fisheries; 2025-2026 Commercial Fishing Restrictions for Pacific Bluefin Tuna in the Eastern Pacific Ocean NOAA-NMFS-2024-0146 | Regulatory Impact Review (RIR) | Supporting & Related Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T22:45:26Z | 0 | 0 | 0900006486894c14 | ||||
| NOAA-NMFS-2024-0146-0003 | NOAA | International Fisheries; Pacific Tuna Fisheries; 2025-2026 Commercial Fishing Restrictions for Pacific Bluefin Tuna in the Eastern Pacific Ocean NOAA-NMFS-2024-0146 | PBF 2024 Environmental Assessment | Supporting & Related Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T22:45:54Z | 0 | 0 | 09000064868959f7 | ||||
| VA-2024-NCA-0017-0005 | VA | AS13-Veterans Legacy Grants Program Improvements VA-2024-NCA-0017 | AS13(F) RIA to publish (12.31.24) Veterans Legacy Grants Program Improvements | Supporting & Related Material | 2024-12-31T05:00:00Z | 2024 | 12 | 2024-12-31T14:20:03Z | 0 | 0 | 090000648689711a | ||||
| AMS-NOP-24-0023-4264 | AMS | National Organic Standards Board Meeting - October 2024 - Portland, OR AMS-NOP-24-0023 | Fall 2024 NOSB Transcripts | Supporting & Related Material | Notice of Availability | 2024-12-30T05:00:00Z | 2024 | 12 | 2024-12-30T19:48:40Z | 0 | 0 | 0900006486895acf | |||
| AMS-NOP-24-0023-4265 | AMS | National Organic Standards Board Meeting - October 2024 - Portland, OR AMS-NOP-24-0023 | Voting Summary Fall 2024_NOSB | Supporting & Related Material | Notice of Availability | 2024-12-30T05:00:00Z | 2024 | 12 | 2024-12-30T19:51:47Z | 0 | 0 | 0900006486895ad1 | |||
| APHIS-2020-0024-0003 | APHIS | Importation of Fresh Pineapple (Ananas comosus) Fruit from Indonesia Into the United States APHIS-2020-0024 | 20-024-1 Pest Risk Assessment for Pineapple Importation from Indonesia | Supporting & Related Material | Risk Assessment | 2024-12-30T05:00:00Z | 2024 | 12 | 2024-12-30T14:27:07Z | 0 | 0 | 090000648687fab8 | |||
| APHIS-2020-0024-0002 | APHIS | Importation of Fresh Pineapple (Ananas comosus) Fruit from Indonesia Into the United States APHIS-2020-0024 | 20-024-1 Risk Management Document for Pineapple Imortation from Indonesia | Supporting & Related Material | Risk Management Document | 2024-12-30T05:00:00Z | 2024 | 12 | 2024-12-30T14:26:52Z | 0 | 0 | 090000648687faba | |||
| APHIS-2020-0024-0004 | APHIS | Importation of Fresh Pineapple (Ananas comosus) Fruit from Indonesia Into the United States APHIS-2020-0024 | 20-024-1 Economic Effects Assessment for Pineapple Importation from Indonesia | Supporting & Related Material | Economic Analysis | 2024-12-30T05:00:00Z | 2024 | 12 | 2024-12-30T14:27:24Z | 0 | 0 | 090000648687fab7 | |||
| CNCS-2024-0028-0002 | CNCS | AmeriCorps Member Application, Enrollment, and Exit Forms CNCS-2024-0028 | 2024 AmeriCorps Member Application Enrollment and Exit Form instrument for comment | Supporting & Related Material | 2024-12-30T05:00:00Z | 2024 | 12 | 2024-12-31T01:32:17Z | 0 | 0 | 0900006486894afe | ||||
| DEA-2024-0144-0003 | DEA | Schedules of Controlled Substances: Placement of 4-Chloromethcathinone in Schedule I (DEA1246) DEA-2024-0144 | 4-CMC HHS 8FA Review | Supporting & Related Material | 2024-12-30T05:00:00Z | 2024 | 12 | 2024-12-30T17:15:04Z | 0 | 0 | 0900006486891597 | ||||
| DEA-2024-0144-0004 | DEA | Schedules of Controlled Substances: Placement of 4-Chloromethcathinone in Schedule I (DEA1246) DEA-2024-0144 | 4-CMC DEA 8 Factor Analysis_092024 | Supporting & Related Material | 2024-12-30T05:00:00Z | 2024 | 12 | 2024-12-30T17:15:09Z | 0 | 0 | 0900006486891598 | ||||
| DEA-2024-0144-0002 | DEA | Schedules of Controlled Substances: Placement of 4-Chloromethcathinone in Schedule I (DEA1246) DEA-2024-0144 | SIGNED - OASH to DEA Ltr 4-CMC.VAS | Supporting & Related Material | 2024-12-30T05:00:00Z | 2024 | 12 | 2024-12-30T17:15:00Z | 0 | 0 | 0900006486891596 | ||||
| EPA-R09-OAR-2024-0228-0065 | EPA | None EPA-R09-OAR-2024-0228 | D.21. Reasonable Further Progress: Rate-Of-Progress Plan, San Bernardino County Portion of the Southeast Desert AQMA (October 5, 1994) | Supporting & Related Material | 2024-12-30T05:00:00Z | 2024 | 12 | 2024-12-31T02:04:20Z | 0 | 0 | 090000648687aae9 | ||||
| EPA-R09-OAR-2024-0228-0044 | EPA | None EPA-R09-OAR-2024-0228 | D.1. Air Quality Implementation Plans; Restructuring SIP Preparation Regulations, 51 FR 40656 (November 7, 1986) | Supporting & Related Material | 2024-12-30T05:00:00Z | 2024 | 12 | 2024-12-31T02:08:50Z | 0 | 0 | 090000648687a9d0 | ||||
| EPA-R09-OAR-2024-0228-0047 | EPA | None EPA-R09-OAR-2024-0228 | D.5. Prevention of Significant Deterioration (PSD) and Nonattainment New Source Review (NSR), 61 FR 38250 (July 23, 1996) | Supporting & Related Material | 2024-12-30T05:00:00Z | 2024 | 12 | 2024-12-31T02:06:12Z | 0 | 0 | 090000648687aa7f |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;